People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Pharmaceuticals, Pharma, Biotechnology, Healthtech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LumiraDx Ltd | — | Other Health Care | Series D+ | $779.1M | $3.5B | 2020 |
| Apnimed, Inc. | — | Pharmaceuticals | Series C | $321.8M | $121.5M | 2018 |
| Cognito Therapeutics Group, Inc. | — | Pharma | Series D+ | $196.3M | $1.7B | 2025 |
| Atea Pharmaceuticals, Inc. | — | Biotechnology | Series D+ | $175.9M | $4.4B | 2016 |
| Apellis Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $140.2M | $703.0M | 2013 |
| Cognito Therapeutics Ltd. | — | Pharma | Series D+ | $119.0M | $111.6M | 2022 |
| Linus Health, Inc. | — | Healthtech | Series C | $53.8M | $859.2M | 2020 |
| Stavvy, Inc. | — | Other Technology | Series A | $36.1M | $103.4M | 2019 |
| Stealth BioTherapeutics Corp | — | Biotechnology | Series B | $35.0M | $793.8M | 2019 |
| Anaconda, INC. | — | Other Technology | Series A | $18.8M | $51.1M | 2021 |
| Natural Polymer International Corp | — | Manufacturing | Seed | $2.6M | $31.6M | 2012 |
| Good Foodie Co | — | Other | Seed | $2.5M | $46.5M | 2016 |
| Critical Biologics Corp | — | Biotechnology | Pre-Seed | $500K | $27.6M | 2009 |
Gerald Chan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gerald Chan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Bruso | 2 | 9 |
| Stephanie O'Brien | 2 | 7 |
| Richard Kuntz | 2 | 4 |
| Helen Liang | 2 | 4 |
| Laura Brege | 2 | 3 |
| Lu Huang | 2 | 2 |
| BIHUA CHEN | 1 | 14 |
| David Scott | 1 | 12 |
| Daniel White | 1 | 10 |
| Lawrence Miller | 1 | 8 |
| Franklin Berger | 1 | 7 |
| RON ZWANZIGER | 1 | 6 |
| David Bates | 1 | 5 |
| Travis Oliphant | 1 | 5 |
| Fan Yu | 1 | 4 |
| James W. Fordyce | 1 | 4 |
| Travis E Oliphant | 1 | 4 |
| Cedric Francois | 1 | 4 |
| Alec Machiels | 1 | 3 |
| Sinclair Dunlop | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.